Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...

Allworth Financial LP boosted its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 12.9% in the fourth quarter, ...

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...

AstraZeneca’s ( www.AstraZeneca.com) flagship health equity programme - Healthy Heart Africa (HHA), marks its 10th ...

Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently ...

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities & ...

Amgen continues to be a key player in the Global Biopharmaceuticals Market. AstraZeneca PLC is a global biopharmaceutical company with a broad portfolio of products focused on treating diseases in ...

Dubai: A new executive committee has taken charge at the Pharmaceutical Research and Manufacturers Association Gulf for the ...

This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a ...

I joined AstraZeneca in September 2017 and this is my dream job, leading respiratory research up until phase 3 clinical trials for one of the largest respiratory-focused global biopharmaceutical ...